Translational Development Acquisition (TDAC) Treasury Shares (2023 - 2026)

Translational Development Acquisition's Treasury Shares history runs 4 years deep, the most recent figure standing at $17.2 million for Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $17.2 million, changed 0.0% from the prior year.
• Treasury Shares was $17.2 million for Q1 2026 at Translational Development Acquisition, roughly flat from $17.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $17.2 million in Q4 2023 and bottomed at $17.2 million in Q4 2023.
• A 4-year average of $17.2 million and a median of $17.2 million in 2023 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
• Translational Development Acquisition's Treasury Shares stood at $17.2 million in 2023, then changed by 0.0% to $17.2 million in 2024, then changed by 0.0% to $17.2 million in 2025, then changed by 0.0% to $17.2 million in 2026.
• Business Quant data shows TDAC's Treasury Shares at $17.2 million in Q1 2026, $17.2 million in Q4 2025, and $17.2 million in Q3 2025.